Extended Oxygen Generating System for Mastitis Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for internal microbial infections, such as mastitis in dairy cows, are ineffective and often lead to unwanted side effects, and there is a need for a non-antibiotic method that can safely and effectively target pathogens in low oxygen environments within the body.
Innovation Solution
An extended acting oxygen generating system is used to enhance the bacteriostatic/bactericidal effect of formulations for treating mastitis and other internal infections, utilizing endogenous Lactoperoxidase (Lp) and substrates, such as thiocyanate, to increase oxygen levels and stimulate the animal's natural defense mechanisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat mastitis, then the anti-microbial effect is achieved, but withholding periods are required and resistance develops
Solution Approach 1:
The patent uses an extended acting oxygen generating system that produces reactive oxygen species (ROS) such as hydrogen peroxide, superoxide, and hydroxyl radicals. These strong oxidants directly kill bacteria through oxidative damage to cellular components, providing a reliable anti-microbial effect without the resistance and withholding period issues associated with antibiotics.
Solution Approach 2:
The patent converts the low oxygen environment, which normally protects bacteria from oxygen-dependent immune responses, into a benefit by using an oxygen-generating system. The system exploits the anaerobic conditions to activate oxygen-sensitive prodrugs and generate ROS in situ, turning the harmful hypoxic environment into a favorable condition for treatment activation.
2Object-affected harmful factors
If natural defense mechanisms such as the Lactoperoxidase system are used, then the treatment is safe, but the system is ineffective in low oxygen environments
Solution Approach 1:
The patent changes the oxygen parameter by introducing an extended acting oxygen generating system that produces ROS in situ. This overcomes the limitation of the natural Lactoperoxidase system which requires oxygen to function, while maintaining safety by using the body's own defense mechanisms activated by the oxygen-generating prodrugs.
Solution Approach 2:
The patent uses oxygen-generating prodrugs as intermediaries that convert molecular oxygen into reactive oxygen species. These ROS act as mediators that activate the Lactoperoxidase system and other oxygen-dependent immune mechanisms, bridging the gap between the safe but ineffective natural system and the need for effective anti-microbial action in hypoxic environments.
3Reliability
If topical compositions are used for microbial infections, then the treatment is effective for surface infections, but internal infections remain difficult to treat
Solution Approach 1:
The patent employs prodrugs that are administered topically but activate themselves at the site of infection through interaction with bacterial enzymes or the hypoxic environment. The oxygen-generating system is triggered in situ, allowing the treatment to serve itself and become effective for internal infections without requiring complex delivery systems.
Solution Approach 2:
The use of strong oxidants in the form of ROS generated by the oxygen-generating system provides potent anti-microbial activity that can penetrate and effectively treat internal infections, overcoming the limitation of topical compositions that are ineffective for internal applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The extended acting oxygen generating system effectively increases oxygen levels at infection sites, boosting the Lp reaction and enhancing the animal's natural antimicrobial defenses, providing a safer and more effective treatment for mastitis and other microbial infections without the need for additional antibiotics.
Implementation Method 1
an extended acting oxygen generating system which can provide a slow release of oxygen
Implementation Method 2
The Lp system provides a defense mechanism, which can produce a natural bactericidal agent
Implementation Method 3
lactoperoxidase (Lp) system provides a defense mechanism, which can produce a natural bactericidal agent
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A medicament for the treatment or prevention of a microbial infection or an associated condition in a low oxygen environment characterised in that the medicament includes an extended acting oxygen generating system.